These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15960574)

  • 1. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
    Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
    J Clin Psychiatry; 2005 Jun; 66(6):774-80. PubMed ID: 15960574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
    Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
    Maturitas; 2007 Jan; 56(1):54-60. PubMed ID: 16835012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
    Reeves H; Batra S; May RS; Zhang R; Dahl DC; Li X
    J Clin Psychiatry; 2008 Aug; 69(8):1228-1236. PubMed ID: 18681749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG; Clayton A; Bao W; Guico-Pabia CJ
    Menopause; 2014 Aug; 21(8):799-806. PubMed ID: 24448103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
    Simon JS; Nemeroff CB
    J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG; Jiang Q; Reddy S; Musgnung JJ; Guico-Pabia CJ
    J Clin Psychiatry; 2010 Aug; 71(8):1088-96. PubMed ID: 20797382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression.
    Keitner GI; Garlow SJ; Ryan CE; Ninan PT; Solomon DA; Nemeroff CB; Keller MB
    J Psychiatr Res; 2009 Jan; 43(3):205-14. PubMed ID: 18586273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is combination olanzapine and antidepressant medication associated with a more rapid response trajectory than antidepressant alone?
    Parker G; Brotchie H; Parker K
    Am J Psychiatry; 2005 Apr; 162(4):796-8. PubMed ID: 15800157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
    Feiger AD; Rickels K; Rynn MA; Zimbroff DL; Robinson DS
    J Clin Psychiatry; 2006 Sep; 67(9):1354-61. PubMed ID: 17017821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
    Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
    Soares CN; Almeida OP; Joffe H; Cohen LS
    Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
    DeMartinis NA; Yeung PP; Entsuah R; Manley AL
    J Clin Psychiatry; 2007 May; 68(5):677-88. PubMed ID: 17503976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
    Schmidt PJ; Ben Dor R; Martinez PE; Guerrieri GM; Harsh VL; Thompson K; Koziol DE; Nieman LK; Rubinow DR
    JAMA Psychiatry; 2015 Jul; 72(7):714-26. PubMed ID: 26018333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
    J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
    Holtzheimer PE; Meeks TW; Kelley ME; Mufti M; Young R; McWhorter K; Vito N; Chismar R; Quinn S; Dey S; Byrd EH; McDonald WM
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):625-31. PubMed ID: 18058832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.